Stability of concentrated trimethoprim-sulfamethoxazole admixtures
- PMID: 2785757
Stability of concentrated trimethoprim-sulfamethoxazole admixtures
Abstract
The stability of trimethoprim-sulfamethoxazole (TMP-SMX) at various concentrations in 5% dextrose injection or 0.9% sodium chloride injection was studied. Appropriate volumes of TMP-SMX formulation (80 mg TMP and 400 mg SMX/5 mL) were mixed with 5% dextrose injection or 0.9% sodium chloride injection to provide dilutions of 1:25 v/v, 1:20 v/v, 1:15 v/v, and 1:10 v/v. Aliquots were removed at 0, 0.5, 1, 2, 4, 8, 14, 24, and 48 hours and filtered. The pH of the samples was determined, and the samples were assayed for trimethoprim and sulfamethoxazole content by high-performance liquid chromatography. Admixtures were visually inspected for precipitate before each sample was removed. The concentration of SMX in all admixtures did not change during the study period. The stability of TMP was dependent on concentration and vehicle. At a 1:25 v/v dilution, TMP was stable for 48 hours in 5% dextrose injection and 0.9% sodium chloride injection. At a 1:20 v/v dilution, TMP was stable for 24 hours in 5% dextrose injection and 14 hours in 0.9% sodium chloride injection. At a 1:15 v/v dilution, TMP was stable for four hours in 5% dextrose injection and two hours in 0.9% sodium chloride injection. At a 1:10 v/v dilution, TMP was stable for one hour in 5% dextrose injection and 0.9% sodium chloride injection. Concentrated solutions of TMP-SMX should be prepared in 5% dextrose injection, infused within one hour of preparation, and visually inspected for precipitation before and during infusion.
Similar articles
-
Stability of trimethoprim-sulfamethoxazole injection in two infusion fluids.Am J Hosp Pharm. 1981 Jul;38(7):1004-6. Am J Hosp Pharm. 1981. PMID: 7258196
-
Stability of trimethoprim-sulfamethoxazole injection in five infusion fluids.Am J Hosp Pharm. 1982 Oct;39(10):1681-4. Am J Hosp Pharm. 1982. PMID: 6983297
-
Solubilities of trimethoprim and sulfamethoxazole at various pH values and crystallization of trimethoprim from infusion fluids.J Parenter Sci Technol. 1991 May-Jun;45(3):147-51. J Parenter Sci Technol. 1991. PMID: 1886043
-
Practical guidelines for preparing and administering amphotericin B.Am J Hosp Pharm. 1992 May;49(5):1156-64. Am J Hosp Pharm. 1992. PMID: 1595747 Review.
-
Analysis of the Clinical Characteristics of Hyponatremia Induced by Trimethoprim/Sulfamethoxazole.Pharmacology. 2022;107(7-8):351-358. doi: 10.1159/000523824. Epub 2022 Apr 5. Pharmacology. 2022. PMID: 35381593 Free PMC article. Review.
Cited by
-
Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions.Eur J Hosp Pharm. 2018 Oct;25(e2):e102-e108. doi: 10.1136/ejhpharm-2017-001225. Epub 2017 Jul 19. Eur J Hosp Pharm. 2018. PMID: 31157078 Free PMC article.
-
Use of Extracorporeal Membrane Oxygenation in Pneumocystis Pneumonia of an Infant with AIDS.Case Rep Pediatr. 2020 Nov 18;2020:8840131. doi: 10.1155/2020/8840131. eCollection 2020. Case Rep Pediatr. 2020. PMID: 33294246 Free PMC article.